Martin Binder

Martin Binder

Auto-generated profile, based on publicly available information

Martin Binder

F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KPKurt Püntener
Kurt Püntener
AGAnna-Lena Glass
Anna-Lena Glass
LTLeonardo Tensi
Leonardo Tensi
BCBin Chen
Bin Chen
KPKatarzyna A. Piechowicz
Katarzyna A. Piechowicz
SHStefan Hildbrand
Stefan Hildbrand

18 August 2026 in Organic Letters
Verified
Journal Article
Closed access
LULorenz Urner
Lorenz Urner
JKJoel Kym
Joel Kym
HPHelena D. Pickford
Helena D. Pickford
AOAnna Onyszczak
Anna Onyszczak
IKIsabel Kissling
Isabel Kissling
WHWolfgang Haap
Wolfgang Haap

8 October 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BBBenjamin Brennecke
Benjamin Brennecke
LPLouise Plais
Louise Plais
BHBenoit Hornsperger
Benoit Hornsperger
MBMartin Binder
Martin Binder
CBChristian Bartelmus
Christian Bartelmus
Uwe GretherUwe Grether
Uwe Grether

14 July 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
MMMason Minot
Mason Minot
YSYannick Stenzhorn
Yannick Stenzhorn
JWJens Wolfard
Jens Wolfard
SSSebastian Strobel
Sebastian Strobel
PJPhilippe Jablonski
Philippe Jablonski
GSGisbert Schneider
Gisbert Schneider
Late-stage functionalization (LSF) is a critical approach for optimizing complex molecules during the advanced stages of drug discovery. Although computational models offer a pivotal opportunity to enhance LSF by predicting reaction outcome, their current impact is constrained by insufficient reference data and the challenge of accurately predicting reaction regioselectivity. To address these critical limitations, we present an integrated closed-loop workflow that combines efficient reaction data acquisition with high-accuracy deep learning. We developed an active learning strategy, driven by a computationally efficient tree-based ensemble, to guide the acquisition of the most informative laboratory experiments. This experimental campaign produced new reactions on novel and complex substrates, yielding the most diverse benchmark yet reported for C–H borylation. The profoundly expanded bespoke dataset allowed us to train and evaluate geometric graph neural networks. We demonstrate that augmenting these symmetry-aware models with self-supervised auxiliary tasks consistently improves performance for both reaction outcome prediction and regioselectivity prediction. Prospective tests on unseen substrates, featuring challenging N-heteroaryl motifs, pinpointed the correct borylation positions in all cases, thereby closing the loop between model-guided experimentation and deep learning, and illustrating the practical utility of our workflow for efficient drug optimization.